These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9797347)

  • 1. Calcium pump overexpression and myocardial function. Implications for gene therapy of myocardial failure.
    Hasenfuss G
    Circ Res; 1998 Nov; 83(9):966-8. PubMed ID: 9797347
    [No Abstract]   [Full Text] [Related]  

  • 2. Overexpression of the Na/Ca exchanger and reduced SERCa function.
    Terracciano CM; MacLeod KT
    Cardiovasc Res; 2001 Apr; 50(1):167-9. PubMed ID: 11345943
    [No Abstract]   [Full Text] [Related]  

  • 3. Adenovirus gene transfer of SERCA in heart failure. A promising therapeutic approach ?
    Baartscheer A
    Cardiovasc Res; 2001 Feb; 49(2):249-52. PubMed ID: 11164834
    [No Abstract]   [Full Text] [Related]  

  • 4. SERCA upregulation: breaking the positive feedback in heart failure?
    Bassani JW; Bassani RA
    Cardiovasc Res; 2005 Sep; 67(4):581-2. PubMed ID: 16018992
    [No Abstract]   [Full Text] [Related]  

  • 5. Sarcoplasmic reticulum gene expression in cardiac hypertrophy and heart failure.
    Arai M; Matsui H; Periasamy M
    Circ Res; 1994 Apr; 74(4):555-64. PubMed ID: 8137493
    [No Abstract]   [Full Text] [Related]  

  • 6. Heterogeneous transmural gene expression of calcium-handling proteins and natriuretic peptides in the failing human heart.
    Krause SM
    Cardiovasc Res; 1999 Aug; 43(2):279-81. PubMed ID: 10536655
    [No Abstract]   [Full Text] [Related]  

  • 7. Local CA(2+) release in heart failure: timing is important.
    Sipido KR
    Circ Res; 2000 Nov; 87(11):966-8. PubMed ID: 11090539
    [No Abstract]   [Full Text] [Related]  

  • 8. Overwhelming evidence of the beneficial effects of SERCA gene transfer in heart failure.
    del Monte F; Hajjar RJ; Harding SE
    Circ Res; 2001 Jun; 88(11):E66-7. PubMed ID: 11397790
    [No Abstract]   [Full Text] [Related]  

  • 9. [Sarcoplasmic reticulum function and heart failure: a novel therapeutic target for heart failure].
    Minamisawa S; Ikeda Y
    Clin Calcium; 2006 Jan; 16(1):37-44. PubMed ID: 16397349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Captopril treatment improves the sarcoplasmic reticular Ca(2+) transport in heart failure due to myocardial infarction.
    Shao Q; Ren B; Zarain-Herzberg A; Ganguly PK; Dhalla NS
    J Mol Cell Cardiol; 1999 Sep; 31(9):1663-72. PubMed ID: 10471350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sarcoplasmic reticulum Ca2+-ATPase modulates cardiac contraction and relaxation.
    Frank KF; Bölck B; Erdmann E; Schwinger RH
    Cardiovasc Res; 2003 Jan; 57(1):20-7. PubMed ID: 12504810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium regulatory proteins and their alteration by transgenic approaches.
    Dillmann WH
    Am J Cardiol; 1999 Jun; 83(12A):89H-91H. PubMed ID: 10750595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transgenic rat hearts overexpressing SERCA2a show improved contractility under baseline conditions and pressure overload.
    Müller OJ; Lange M; Rattunde H; Lorenzen HP; Müller M; Frey N; Bittner C; Simonides W; Katus HA; Franz WM
    Cardiovasc Res; 2003 Aug; 59(2):380-9. PubMed ID: 12909321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phospholamban: a key determinant of cardiac function and dysfunction.
    Rodriguez P; Kranias EG
    Arch Mal Coeur Vaiss; 2005 Dec; 98(12):1239-43. PubMed ID: 16435604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of cardiac function and suppression of heart failure progression by inhibition of protein phosphatase 1.
    Pathak A; del Monte F; Zhao W; Schultz JE; Lorenz JN; Bodi I; Weiser D; Hahn H; Carr AN; Syed F; Mavila N; Jha L; Qian J; Marreez Y; Chen G; McGraw DW; Heist EK; Guerrero JL; DePaoli-Roach AA; Hajjar RJ; Kranias EG
    Circ Res; 2005 Apr; 96(7):756-66. PubMed ID: 15746443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re-evaluating sarcoplasmic reticulum function in heart failure.
    Delling U; Sussman MA; Molkentin JD
    Nat Med; 2000 Sep; 6(9):942-3. PubMed ID: 10973288
    [No Abstract]   [Full Text] [Related]  

  • 17. SERCA2a in heart failure: role and therapeutic prospects.
    Gianni D; Chan J; Gwathmey JK; del Monte F; Hajjar RJ
    J Bioenerg Biomembr; 2005 Dec; 37(6):375-80. PubMed ID: 16691468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in sarcoplasmic reticulum gene expression in human heart failure. A possible mechanism for alterations in systolic and diastolic properties of the failing myocardium.
    Arai M; Alpert NR; MacLennan DH; Barton P; Periasamy M
    Circ Res; 1993 Feb; 72(2):463-9. PubMed ID: 8418995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased Na(+)-Ca(2+) exchanger in the failing heart.
    Pogwizd SM
    Circ Res; 2000 Oct; 87(8):641-3. PubMed ID: 11029397
    [No Abstract]   [Full Text] [Related]  

  • 20. Reverse mode of the sarcoplasmic reticulum Ca pump limits sarcoplasmic reticulum Ca uptake in permeabilized and voltage-clamped myocytes.
    Shannon TR; Ginsburg KS; Bers DM
    Ann N Y Acad Sci; 1998 Sep; 853():350-2. PubMed ID: 10603977
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.